Sialix closes series B
Biotechnology company Sialix has closed an oversubscribed $1.2 million tranche of an angel-led financing. Investors included Boston Harbor Angels, Mass Medic Angels, Launchpad Angels, Maine Angels, Beacon Angels and Desert Angels as well as other undisclosed individuals.
6 February 2014•2 mins read
